Auxeris Therapeutics
About:
Auxeris Therapeutics is a biopharmaceutical company focused on the treatment of bone diseases.
Top Investors: Domain Associates, RiverVest
Description:
Auxeris Therapeutics is a biopharmaceutical company focused on the development and commercialization of medicines to treat a broad range of bone diseases. The company develops drugs to treat fracture repair, spinal fusion, and bone diseases, including osteoporosis. Auxeris Therapeutics was founded in 2002 and is based in St. Louis, Missouri.
Total Funding Amount:
$1.6M
Headquarters Location:
St Louis, Missouri, United States
Founded Date:
2002-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2004-01-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai